Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.69 is in line with its 5-year average of 1.82, near the low end of its 5-year range (0.03–27.07).
As of the fiscal period ended Tuesday, June 30, 2026. 303.97% above its 12-month average of 0.42.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 1.69.
QUICK RATIO (ACID-TEST)
1.69
QUICK RATIO (ACID-TEST) AVG TTM
0.42
QUICK RATIO (ACID-TEST) AVG 3Y
0.43
QUICK RATIO (ACID-TEST) AVG 5Y
1.82
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+303.97%
CURRENT VS 3Y AVG
+289.48%
CURRENT VS 5Y AVG
-6.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.07
median of 689 covered companies
CURRENT VS SECTOR MEDIAN
-44.93%
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.44M
Quick Ratio (Acid-Test)
1.69
TTM Avg
0.42
3Y Avg
0.43
5Y Avg
1.82
Market Cap
$13.30M
Quick Ratio (Acid-Test)
1.22
TTM Avg
3.07
3Y Avg
6.03
5Y Avg
8.35
Market Cap
$13.29M
Quick Ratio (Acid-Test)
0.50
TTM Avg
1.75
3Y Avg
2.03
5Y Avg
3.39
Market Cap
$13.83M
Quick Ratio (Acid-Test)
4.37
TTM Avg
1.21
3Y Avg
1.25
5Y Avg
1.53
Market Cap
$12.93M
Quick Ratio (Acid-Test)
6.66
TTM Avg
2.77
3Y Avg
1.93
5Y Avg
5.53
Market Cap
$14.15M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.15
3Y Avg
4.02
5Y Avg
6.30
Market Cap
$12.54M
Quick Ratio (Acid-Test)
0.99
TTM Avg
0.99
3Y Avg
1.05
5Y Avg
1.43
Market Cap
$14.37M
Quick Ratio (Acid-Test)
1.69
TTM Avg
7.45
3Y Avg
9.35
5Y Avg
10.55
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.44M | 1.69 | 0.42 | 0.43 | 1.82 |
| Passage Bio, Inc. (PASG)vs › | $13.30M | 1.22 | 3.07 | 6.03 | 8.35 |
| IN8bio, Inc. (INAB)vs › | $13.71M | 8.21 | 6.45 | 5.32 | 7.60 |
| Cytosorbents Corporation (CTSO)vs › | $13.29M | 0.50 | 1.75 | 2.03 | 3.39 |
| Vyome Holdings, Inc. (HIND)vs › | $13.83M | 4.37 | 1.21 | 1.25 | 1.53 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.93M | 6.66 | 2.77 | 1.93 | 5.53 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.15M | 0.40 | 0.15 | 4.02 | 6.30 |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | 0.99 | 0.99 | 1.05 | 1.43 |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.37M | 1.69 | 7.45 | 9.35 | 10.55 |
| Lantern Pharma Inc. (LTRN)vs › | $12.47M | 1.96 | 4.12 | 11.35 | 18.88 |
Quick Ratio
1.69
Excludes inventory
Current Ratio
1.73
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.69 |
| 2026-03-31 | 0.03 |
| 2025-12-31 | 0.09 |
| 2025-09-30 | 0.18 |
| 2025-06-30 | 0.11 |
| 2025-03-31 | 0.05 |
| 2024-12-31 | 0.08 |
| 2024-09-30 | 0.11 |
| 2024-06-30 | 0.31 |
| 2024-03-31 | 0.35 |
| 2023-12-31 | 0.79 |
| 2023-09-30 | 1.02 |
| 2023-06-30 | 0.84 |
| 2023-03-31 | 2.88 |
| 2022-12-31 | 5.15 |
| 2022-09-30 | 2.97 |
| 2022-06-30 | 2.61 |
| 2022-03-31 | 3.67 |
| 2021-12-31 | 7.08 |
| 2021-09-30 | 6.33 |
| 2021-06-30 | 27.07 |
| 2021-03-31 | 140.25 |
| 2020-12-31 | 6.67 |
| 2020-06-30 | 0.00 |
